Parallel Advisors, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,637
-66.3%
4350.0%0.00%
Q2 2023$10,805
+65.2%
4350.0%0.00%
Q1 2023$6,542
+27.1%
4350.0%0.00%
Q4 2022$5,146
+71.5%
4350.0%0.00%
Q3 2022$3,000
+50.0%
4350.0%0.00%
Q2 2022$2,000
-80.0%
435
-17.6%
0.00%
Q4 2021$10,000
+400.0%
528
+956.0%
0.00%
Q3 2021$2,0000.0%500.0%0.00%
Q2 2021$2,000
-33.3%
50
-21.9%
0.00%
Q1 2021$3,0000.0%640.0%0.00%
Q4 2020$3,000
+200.0%
64
+42.2%
0.00%
Q3 2020$1,000450.0%0.00%
Q2 2020$0450.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders